-
Registries Report on COVID-19 and Cancer
Data shed light on risk factors for death among people with cancer infected with the coronavirus.
by Kate Yandell
-
When COVID-19 Comes Home
I have brain cancer, and my wife is a health care worker. These are some questions we had to consider leading up to and after her diagnosis with COVID-19.
by Adam Hayden
-
What It’s Like to Get a “C” in Graduate School
I was afraid that my thyroid cancer diagnosis would derail my graduate school plans. Instead, it helped shape my career path.
by Carly Flumer
-
Embracing Palliative Care Sooner
Studies show the benefits palliative care can provide to advanced cancer patients, but also highlight inequities in access.
by Jen Tota McGivney
-
International Perspectives on COVID-19 and Cancer
Researchers from around the globe share insights into the outcomes of people with cancer who are infected with the coronavirus.
by Bradley Jones
-
Tests Spot Signs of Cancer in the Blood
At the AACR Virtual Annual Meeting I, researchers presented data on blood tests that aim to supplement current cancer screening and speed up diagnosis.
by Kate Yandell
-
Using Leftover Cancer Drugs to Help Others
Cancer drug repositories that accept unused drugs could provide an affordable source of medications for patients in need, while also providing patients left with extra drugs a way to give back.
by Jon Kelvey
-
Tumor Testing May Help Guide Pancreatic Cancer Treatment
For a small group of pancreatic cancer patients who were able to receive therapies targeting the molecular alterations in their tumors, these matched therapies were associated with longer life.
by Cheryl Platzman Weinstock
-
Facing Cancer and a Pandemic at the Same Time
Cancer patients and their families share stories of fear, love and uncertainty as they find new ways to support each other.
by Jen Tota McGivney
-
Virtual Connection in a Time of Social Distance
Responding to the coronavirus, patient advocates and nonprofits expand existing outreach initiatives and launch new ones.
by Marci A. Landsmann
Cancer Talk
Researchers Tackle Immune-related Adverse Effects
Scientists present data on the risks of immune checkpoint inhibitors so more patients can tap into the treatment.
by Marci A. Landsmann
Tissue and Liquid Biopsy for Targeted TherapyTailored treatments led to better outcomes than standard of care when biomarker results from liquid biopsy and tumor tissue aligned.
by Eric Fitzsimmons
Cancer Vaccines Show Promise in Early TrialsWhile mRNA vaccines offer a personalized approach to triggering an immune response, peptide vaccines could be a one-size-fits-all treatment. Researchers are exploring both options.
by Thomas Celona
Declining Breast Cancer Mortality in Younger WomenU.S. breast cancer deaths declined for women ages 20 to 49, which researchers credit to wider screening and better treatment.
by Kevin McLaughlin